The use of lepirudin in haemodialysis complicated with heparin-induced thrombocytopenia type II (HIT II)--dosage monitoring.

1. Bettinelli A, Giovanni M, Bianchetti MG et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndrome. J Pediatr 1992; 120: 38–43 2. Lin S-H, Cheng N-L, Hsu Y-J, Halperin ML. Intrafamilial phenotype variability in patients with Gitelman syndrome having the same mutations in their thiazide-sensitive sodium/chloride cotransporter. Am J Kidney Dis 2004; 43: 304–312 3. Kamel KS, Harvey E, Douek K, Halperin ML. Studies on the pathogenesis of hypokalemia in Gitelman’s syndrome: role of bicarbonaturia and hypomagnessemia. Am J Nephrol 1998; 18: 42–49 4. Takeuchi K, Kure S, Kato T et al. Association of a mutation in the thiazide-sensitive Na-Cl cotransporter with familial Gitelman’s syndrome. J Clin Endocr Metab 1996; 81: 4496–4499 5. Tajima T, Kobayashi Y, Abe S et al. Two novel mutations of thiazide-sensitive Na-Cl cotransporter (TSC) gene in two sporadic Japanese patients with Gitelman syndrome. Endocr J 2002; 49: 91–96 6. Tsukamoto T, Kobayashi T, Kawamoto K, Fukase M, Chihara K. Possible discrimination of Gitelman’s syndrome from Bartter’s syndrome by renal clearance study: report of two cases. Am J Kidney Dis 1995; 25: 637–641 7. Baehler RW, Work J, Kotchen TA, McMorrow G, Guthrie G. Studies on the pathogenesis of Bartter’s syndrome. Am J Med 1980; 69: 933–938 8. Uribarri J, Alverabga D, Oh MS, Kukar NM, Del Monte ML, Carroll HJ. Bartter’s syndrome due to a defect in salt reabsorption in the distal convoluted tubule. Nephron 1985; 40: 52–56 9. Stein JH. The pathogenetic spectrum of Bartter’s syndrome. Kidney Int 1985; 28: 85–93